NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Not Allowed)
ID: 355210Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355210

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-219.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the HEAL Initiative PainCare Clinician Training Program (PCTP) through Mentored Clinical Scientist Development Awards (K08), aimed at supporting early-career clinician-scientists focused on clinical pain management research. This program provides funding for a maximum of five years, offering up to $125,000 annually for salary and $50,000 for research-related expenses, with a strong emphasis on rigorous training in responsible research conduct and collaboration among pain researchers. The initiative addresses the urgent need for effective pain management solutions amidst the ongoing chronic pain and opioid crisis affecting millions of Americans. Interested applicants can find more information and apply by July 12, 2027, and should direct inquiries to grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-219-Full-Announcement.html
    PAR-24-219.html
    The NIH HEAL Initiative PainCare Clinician Training Program (PCTP) is aimed at fostering the career development of early-career clinician-scientists focused on clinical pain management research. This program provides mentored clinical scientist development awards (K08) to support individuals with clinical doctoral degrees in creating independent research careers without leading their own clinical trials, although they may participate in trials led by mentors. The initiative responds to the significant need for effective pain management solutions amidst the chronic pain and opioid crisis affecting millions of Americans. Funding is provided for a maximum of five years, offering up to $125,000 annually in salary and $50,000 for research-related expenses. The program emphasizes rigorous training in responsible research conduct and requires participation in annual meetings to enhance networking and collaboration among pain researchers. Eligible candidates must commit at least 75% of their effort to research activities and work under experienced mentors to guide them toward scientific independence. This funding opportunity reflects the federal government's commitment to addressing pressing health crises through strategic investment in research and human capital development, specifically supporting a diverse pool of scientists equipped to tackle complex health challenges related to pain management.
    Similar Opportunities
    NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative PainCare Clinician Training Program (PCTP) through Mentored Clinical Scientist Development Awards (K08), aimed at supporting early-career clinician-scientists in pain management research. This program seeks to cultivate a cohort of independent investigators who will lead clinical trials, thereby enhancing the clinical pain research workforce to address the ongoing chronic pain and opioid crisis. Awardees will receive substantial salary support of up to $125,000 annually, along with additional funding for research-related expenses, and must demonstrate a strong mentoring structure and commitment to health equity in their research proposals. Interested applicants can find more information and application details at the provided NIH link, with a submission deadline of July 12, 2027, and inquiries directed to grantsinfo@nih.gov.
    NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Basic Experimental Studies with Humans (BESH) Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative PainCare Clinician Training Program (PCTP) through the Mentored Clinical Scientist Development Awards (K08), aimed at supporting early-career clinician-scientists focused on clinical pain research. This program seeks to develop independent investigators who will conduct basic experimental studies involving human participants, with a strong emphasis on innovating treatments for chronic pain, which affects over 25 million Americans. Awardees will receive funding of up to $125,000 per year for salary and an additional $50,000 for research development costs, with a commitment of at least 75% full-time effort required. Interested applicants can find more information and guidance by contacting NIH Grants Information at grantsinfo@nih.gov, and the application deadline is July 12, 2027.
    NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative PainCare Clinician Training Program (PCTP), a Mentored Patient-Oriented Research Career Development award (K23), aimed at supporting early-career clinician-scientists in conducting patient-oriented research in pain management. This grant program is designed to cultivate a new cohort of independent researchers capable of leading clinical trials that address chronic pain, a significant health issue affecting over 25 million Americans. Awardees will receive salary support, research expenses, and training in rigorous research methodologies, while also engaging with established mentoring teams and participating in annual networking meetings. The application deadline is July 12, 2027, and interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-220.html.
    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative aimed at supporting research for non-opioid analgesics via the R61/R33 Exploratory/Developmental Phased Award. This initiative encourages applications that focus on the early translational steps in developing novel pain treatment strategies, including the development and validation of assays and the identification of potential therapeutic agents, while explicitly prohibiting clinical trials. The funding amount is up to $350,000 per year, with a total project period not exceeding three years, and applications are due by January 15, 2027. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the HEAL Initiative's funding opportunity titled "Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)." This initiative aims to support pilot projects that identify new druggable targets for pain by generating preliminary data on understudied proteins associated with pain management. The funding opportunity is particularly significant as it seeks to advance research in pain management and drug discovery, contributing to the broader goal of addressing the opioid addiction crisis. Eligible applicants can receive up to $100,000 for projects lasting one year, with applications due by July 16, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-197.html.
    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, titled "Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)." This initiative aims to support early-stage translational research focused on developing and validating tests for non-opioid analgesics, including small molecules and biologics, to address the ongoing opioid crisis and improve pain management. The program anticipates a funding pool of $2.5 million, with plans to award approximately 4-5 grants in FY 2025, and applications are due by January 15, 2027. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the HEAL Initiative: Pain Management Effectiveness Research Network, specifically for Clinical Trial Planning and Implementation through a Cooperative Agreement (UG3/UH3). This initiative aims to conduct large-scale, multisite clinical trials that will evaluate the efficacy of interventions designed to reduce opioid use and improve pain management across various conditions, thereby enhancing functional outcomes for patients suffering from acute to chronic pain. The program is critical in expanding evidence-based therapeutic options for pain relief, benefiting patients and their families. Interested applicants, including various eligible entities such as tribal governments and community organizations, are encouraged to prepare for this opportunity, with applications expected to be solicited starting October 15, 2025, and closing on January 5, 2026. For further inquiries, potential applicants can contact Dr. Yolanda F. Vallejo at 301-451-1751 or via email at Yolanda.Vallejo@nih.gov.
    HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative: Pain Research Enhancement Program (PREP), a federal grant aimed at supporting pain research projects from R15-eligible institutions. This initiative seeks to promote rigorous basic and mechanistic pain research, foster interdisciplinary collaborations, and enhance the research environment for health professional trainees and students. The program is crucial for diversifying the pain research workforce and advancing understanding of pain mechanisms, with funding available up to $375,000 over a maximum three-year period. Applications will be accepted starting October 18, 2024, with a deadline of November 19, 2024, and interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative to support the development of non-addictive analgesic therapeutics, specifically small molecules and biologics, aimed at treating pain. The initiative seeks to accelerate the optimization and transition of promising therapeutic candidates to Phase I clinical trials, requiring applicants to demonstrate a compelling biological rationale and suitable assays for their projects. This funding is crucial for addressing the needs of over 25 million Americans suffering from chronic pain while providing alternatives to opioids. Approximately $11 million is anticipated for distribution across four awards in FY 2024, with applications due by January 24, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative: Pain Research Enhancement Program (PREP), a federal grant aimed at supporting rigorous basic and mechanistic pain research at R15-eligible institutions. This initiative seeks to foster interdisciplinary partnerships between eligible Principal Investigators (PIs) and other U.S. domestic entities, while enhancing the research environment for health professional trainees and students through active engagement in pain research projects. Grants of up to $375,000 are available for a maximum duration of three years, with applications due by 5:00 PM local time on November 23, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage for more details.